Palantir Beat the Numbers. The Valuation Still Doesn't Make Sense.

Palantir posted a second-quarter report that should have satisfied even the most demanding investor. Revenue surged 93% year-over-year to $1.94 billion, beating the $1.80 billion consensus. Earnings per share came in at 41 cents versus 35 cents expected. The U.S. commercial segment - the growth engine that has been doing the heavy lifting - jumped 149% to $764 million and has compounded 380% since 2024. Management raised full-year revenue guidance to between $8.15 billion and $8.16 billion, well above the prior outlook of $7.65 billion to $7.66 billion.

And yet the stock immediately gave back the pop. Shares jumped roughly 8% after the release, then tumbled about 6% the next session, wiping out the gain and leaving investors who chased the beat sitting on paper losses. That reaction tells you everything about the real problem here: the numbers are excellent, but the valuation is not.

Palantir's market cap sits at $301 billion. The forward P/E - what investors are paying for each dollar of expected next-year earnings - is 278 times. The price-to-sales multiple, which measures how much the market is paying for every dollar of annual revenue, stands at 57.7x. Even at the stock's current level of roughly $123.53 - down about 29% year-to-date and roughly 40% from its 52-week high of $207.52 - these multiples are staggering. The company has to deliver near-perfect execution for years just to catch up to what the price already demands.

The growth numbers are extraordinary. Revenue growth of 93% in Q2 is not incremental acceleration - it's compounding momentum. Gross margins of 84%, operating margins of 38%, and a free cash flow margin of 51% show a business model with massive operating leverage. Free cash flow more than doubled year-over-year to $2.69 billion on a trailing twelve-month basis, while capital expenditures were negligible at $35 million. Return on invested capital of 28% and return on equity of 33% are the kind of figures you associate with mature monopolies, not a company still in its growth phase.

But growth quality alone doesn't justify a 278 times forward earnings multiple. Even a company growing at 90% can't sustain that rate indefinitely - and Palantir won't either. CEO Alex Karp told CNBC the current growth trajectory looks like this is going to go on for at least another 18 months. If we take that at face value, the question becomes what happens after 18 months when the growth rate inevitably slows to a more normal number. At 278 times forward earnings, any deceleration creates a severe multiple contraction risk because there's no margin for error baked into the price.

The moat remains intact, which is important. Palantir's Artificial Intelligence Platform (AIP) - the operating system-like software layer that lets organizations deploy AI models on their own data - has created genuine stickiness. The remaining U.S. commercial deal value more than doubled year-over-year to $6.24 billion. The company raised its U.S. commercial revenue guidance for 2026 to "in excess of" $3.42 billion from $3.22 billion. Government revenue grew 90% to $809 million. The balance sheet is pristine: $2.3 billion in cash, minimal debt, and a current ratio of 691%. There's no balance-sheet risk here to worry about.

What has changed is the context the stock is trading in. Throughout 2026, Palantir fell roughly 30% as investors rotated out of enterprise software names amid concerns that new model features from Anthropic and OpenAI could commoditize the AI software layer. IBM's July pre-announcement of softer software demand and ServiceNow's post-earnings dip reinforced a narrative that the enterprise SaaS trade was losing its luster. Palantir's Q2 results punch a hole through that narrative - but the stock is still 40% below its peak because the initial valuation was built on a level of optimism that no earnings report can fully justify.

Price action reinforces the caution. The stock is trading below both its 50-day moving average of $130.49 and its 200-day moving average of $152.62. The RSI sits at 47.7 - neutral territory, not oversold. The MACD is negative at -1.53, pointing bearish. These are not signals of selling exhaustion or a forming bottom. They're signals of a stock that's still working through overhang from its decline and hasn't found a base yet. The pop-and-fade pattern after earnings - up 8%, down 6% - is exactly the kind of reaction you see when the valuation is too rich for buyers to hold with conviction.

AInvest's aggregate analyst consensus rates Palantir a Buy, reflecting the genuine quality of the earnings surprise. But consensus ratings don't price in what happens when a 278 times forward P/E meets even modest growth deceleration two quarters from now.

The takeaway isn't that Palantir is a broken company. It isn't. The growth is real, the margins are elite, and the deal pipeline is accelerating. The takeaway is that an impressive earnings report doesn't fix a valuation that prices in a decade of perfection. I don't think investors should chase this one. The setup would need either a deeper pullback toward the $106 support level - the 52-week low - or a confirmed reversal above the 50-day moving average with volume backing. Until then, the better posture is patience.

I would reassess this view if U.S. commercial growth sustains above 100% for multiple quarters straight, confirming that the AI platform adoption cycle is just entering its inflection rather than approaching its peak. At that point, the growth runway would be longer than the market is pricing in, and the valuation pressure would ease. But right now, the stock is asking investors to assume growth stays exceptional while paying a price that leaves no room for the moment it doesn't.